Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries targets net profits of EGP 4 million in the fiscal year 2016/17, according to its estimated budget.
The company eyes revenues worth EGP 354 million in FY16/17, as well as an amount of EGP 16.3 million in investments.
The drug company suffered losses of EGP 10.3 million in FY 14/15.
